Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Becker

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Minnesota Medicine|May 18, 2004
Imperfect toolsGeorge Schoephoerster, Mark Becker
Matrix Biology Plus|August 6, 2021
Structural studies of elastic fibre and microfibrillar proteinsMukti Singh, Mark Becker, Alan R F Godwin, et al.
Transfusion|August 25, 2023
Why do US source plasma donors stop donating?Michelle Fransen, Mark Becker, Janet Hershman, et al.
Journal of Clinical Pharmacology|October 20, 2006
Pharmacokinetics of nelfinavir in subjects with hepatic impairmentBharat Damle, Dial Hewlett, Poe-Hirr Hsyu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 9, 2025
Investigating the effects of chelating agents, surfactants and magnesium cations on the size of LPS aggregates in formulations causing low endotoxin recovery in limulus amebocyte lysate assaysAmy Gorman, Mark Becker, Clair Baldock, et al.
British Journal of Clinical Pharmacology|July 18, 2006
The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavirDavid M Burger, H Reinier Schwietert, E P H Colbers, et al.
Medical Care Research and Review : MCRR|May 12, 2006
Quality improvement implementation and hospital performance on patient safety indicatorsBryan J Weiner, Jeffrey A Alexander, Laurence C Baker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2009
Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengtheningDenis Nash, Batya Elul, Miriam Rabkin, et al.
Transfusion|August 14, 2021
Plasmavigilance-Adverse events among US Source plasma donorsGeorge B Schreiber, Mark Becker, Michelle Fransen, et al.
Research Square|September 18, 2023
Live imaging of the airway epithelium reveals that mucociliary clearance modulates SARS-CoV-2 spreadThomas Hope, Mark Becker, Laura Martin-Sancho, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Minnesota Medicine|May 18, 2004
Imperfect toolsGeorge Schoephoerster, Mark Becker
Matrix Biology Plus|August 6, 2021
Structural studies of elastic fibre and microfibrillar proteinsMukti Singh, Mark Becker, Alan R F Godwin, et al.
Transfusion|August 25, 2023
Why do US source plasma donors stop donating?Michelle Fransen, Mark Becker, Janet Hershman, et al.
Journal of Clinical Pharmacology|October 20, 2006
Pharmacokinetics of nelfinavir in subjects with hepatic impairmentBharat Damle, Dial Hewlett, Poe-Hirr Hsyu, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 9, 2025
Investigating the effects of chelating agents, surfactants and magnesium cations on the size of LPS aggregates in formulations causing low endotoxin recovery in limulus amebocyte lysate assaysAmy Gorman, Mark Becker, Clair Baldock, et al.
British Journal of Clinical Pharmacology|July 18, 2006
The effect of the CYP2C19*2 heterozygote genotype on the pharmacokinetics of nelfinavirDavid M Burger, H Reinier Schwietert, E P H Colbers, et al.
Medical Care Research and Review : MCRR|May 12, 2006
Quality improvement implementation and hospital performance on patient safety indicatorsBryan J Weiner, Jeffrey A Alexander, Laurence C Baker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2009
Strategies for more effective monitoring and evaluation systems in HIV programmatic scale-up in resource-limited settings: Implications for health systems strengtheningDenis Nash, Batya Elul, Miriam Rabkin, et al.
Transfusion|August 14, 2021
Plasmavigilance-Adverse events among US Source plasma donorsGeorge B Schreiber, Mark Becker, Michelle Fransen, et al.
Research Square|September 18, 2023
Live imaging of the airway epithelium reveals that mucociliary clearance modulates SARS-CoV-2 spreadThomas Hope, Mark Becker, Laura Martin-Sancho, et al.
Pageof 3